1. Home
  2. RAVE vs PDSB Comparison

RAVE vs PDSB Comparison

Compare RAVE & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rave Restaurant Group Inc.

RAVE

Rave Restaurant Group Inc.

HOLD

Current Price

$2.83

Market Cap

38.5M

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.92

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RAVE
PDSB
Founded
1958
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
38.5M
46.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
RAVE
PDSB
Price
$2.83
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
53.4K
645.4K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
9.08
N/A
EPS
0.20
N/A
Revenue
$12,202,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.50
N/A
Revenue Growth
0.73
N/A
52 Week Low
$2.01
$0.70
52 Week High
$3.75
$2.20

Technical Indicators

Market Signals
Indicator
RAVE
PDSB
Relative Strength Index (RSI) 43.40 52.42
Support Level $2.87 $0.83
Resistance Level $3.01 $1.13
Average True Range (ATR) 0.17 0.08
MACD -0.02 0.02
Stochastic Oscillator 4.17 51.73

Price Performance

Historical Comparison
RAVE
PDSB

About RAVE Rave Restaurant Group Inc.

Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn Franchising and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The corporate administration and other segments. The Pizza Inn Franchising segment accounts for the majority of the company's revenue. Geographically, it generates the majority of the revenue from the United States.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: